Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Finance

Seeking deals from all areas of U.S. and Canada, Lumira raises $220M fourth fund

About 80% will go to therapeutics, the remainder to medtech

July 26, 2021 10:38 PM UTC

Canada’s Lumira Ventures expects to invest its largest fund yet across North America, with particular emphasis on geographies less well served by other biotech VCs. The firm believes it’s the largest institutional life sciences venture capital fund ever raised in Canada.

On Monday, Lumira announced its $220 million fourth fund, the firm’s first raised in U.S. dollars. The vehicle is roughly 55% larger than Lumira’s 2017-vintage, C$178.5 million ($142 million) third fund...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article